Annual total expenses:
$873.52M+$73.70M(+9.21%)Summary
- As of today (May 18, 2025), ACAD annual total expenses is $873.52 million, with the most recent change of +$73.70 million (+9.21%) on December 31, 2024.
- During the last 3 years, ACAD annual total expenses has risen by +$218.93 million (+33.45%).
- ACAD annual total expenses is now at all-time high.
Performance
ACAD Total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly total expenses:
$225.03M-$27.59M(-10.92%)Summary
- As of today (May 18, 2025), ACAD quarterly total expenses is $225.03 million, with the most recent change of -$27.59 million (-10.92%) on March 31, 2025.
- Over the past year, ACAD quarterly total expenses has increased by +$34.41 million (+18.05%).
- ACAD quarterly total expenses is now -16.49% below its all-time high of $269.48 million, reached on September 30, 2023.
Performance
ACAD Quarterly total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
ACAD Total expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.2% | +18.1% |
| 3 y3 years | +33.5% | -1.5% |
| 5 y5 years | +49.2% | +25.3% |
ACAD Total expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +33.5% | -16.5% | +39.3% |
| 5 y | 5-year | at high | +49.2% | -16.5% | +53.2% |
| alltime | all time | at high | +5506.3% | -16.5% | +5347.7% |
ACAD Total expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $225.03M(-10.9%) |
| Dec 2024 | $873.52M(+9.2%) | $252.61M(+15.5%) |
| Sep 2024 | - | $218.76M(+3.4%) |
| Jun 2024 | - | $211.53M(+11.0%) |
| Mar 2024 | - | $190.62M(-2.8%) |
| Dec 2023 | $799.82M(+8.0%) | $196.10M(-27.2%) |
| Sep 2023 | - | $269.48M(+66.1%) |
| Jun 2023 | - | $162.20M(-5.7%) |
| Mar 2023 | - | $172.05M(-5.8%) |
| Dec 2022 | $740.83M(+13.2%) | $182.55M(+13.0%) |
| Sep 2022 | - | $161.58M(-3.9%) |
| Jun 2022 | - | $168.21M(-26.4%) |
| Mar 2022 | - | $228.48M(+30.3%) |
| Dec 2021 | $654.58M(-10.1%) | $175.41M(+19.4%) |
| Sep 2021 | - | $146.91M(-7.6%) |
| Jun 2021 | - | $158.93M(-8.3%) |
| Mar 2021 | - | $173.33M(-7.9%) |
| Dec 2020 | $728.34M(+24.4%) | $188.17M(-8.9%) |
| Sep 2020 | - | $206.48M(+34.0%) |
| Jun 2020 | - | $154.11M(-14.2%) |
| Mar 2020 | - | $179.58M(+16.1%) |
| Dec 2019 | $585.62M(+24.3%) | $154.72M(+10.5%) |
| Sep 2019 | - | $140.01M(-0.2%) |
| Jun 2019 | - | $140.30M(-6.8%) |
| Mar 2019 | - | $150.59M(+18.7%) |
| Dec 2018 | $471.25M(+12.9%) | $126.85M(+6.1%) |
| Sep 2018 | - | $119.58M(-1.3%) |
| Jun 2018 | - | $121.14M(+16.8%) |
| Mar 2018 | - | $103.69M(-8.7%) |
| Dec 2017 | $417.31M(+43.8%) | $113.57M(+12.2%) |
| Sep 2017 | - | $101.22M(+2.8%) |
| Jun 2017 | - | $98.51M(-5.3%) |
| Mar 2017 | - | $104.01M(+15.3%) |
| Dec 2016 | $290.15M(+76.2%) | $90.19M(+16.1%) |
| Sep 2016 | - | $77.67M(+7.8%) |
| Jun 2016 | - | $72.02M(+43.3%) |
| Mar 2016 | - | $50.27M(+10.3%) |
| Dec 2015 | $164.67M(+76.4%) | $45.58M(+16.8%) |
| Sep 2015 | - | $39.04M(-1.2%) |
| Jun 2015 | - | $39.50M(-2.6%) |
| Mar 2015 | - | $40.56M(+41.8%) |
| Dec 2014 | $93.35M(+136.7%) | $28.60M(+14.4%) |
| Sep 2014 | - | $25.01M(+15.0%) |
| Jun 2014 | - | $21.75M(+20.9%) |
| Mar 2014 | - | $17.99M(+47.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | $39.44M(+52.9%) | $12.20M(+10.4%) |
| Sep 2013 | - | $11.05M(+15.0%) |
| Jun 2013 | - | $9.61M(+46.0%) |
| Mar 2013 | - | $6.58M(-8.6%) |
| Dec 2012 | $25.79M(+3.5%) | $7.20M(+22.3%) |
| Sep 2012 | - | $5.88M(-2.4%) |
| Jun 2012 | - | $6.03M(-9.8%) |
| Mar 2012 | - | $6.68M(+13.2%) |
| Dec 2011 | $24.92M(-7.8%) | $5.90M(+4.0%) |
| Sep 2011 | - | $5.68M(-19.4%) |
| Jun 2011 | - | $7.04M(+11.9%) |
| Mar 2011 | - | $6.30M(+0.3%) |
| Dec 2010 | $27.04M(-47.9%) | $6.28M(-4.1%) |
| Sep 2010 | - | $6.54M(-0.8%) |
| Jun 2010 | - | $6.59M(-13.6%) |
| Mar 2010 | - | $7.63M(-27.2%) |
| Dec 2009 | $51.87M(-24.4%) | $10.47M(-6.5%) |
| Sep 2009 | - | $11.21M(-23.4%) |
| Jun 2009 | - | $14.64M(-5.8%) |
| Mar 2009 | - | $15.54M(+6.9%) |
| Dec 2008 | $68.57M(-2.3%) | $14.54M(-11.2%) |
| Sep 2008 | - | $16.37M(-14.8%) |
| Jun 2008 | - | $19.22M(-0.1%) |
| Mar 2008 | - | $19.25M(-5.1%) |
| Dec 2007 | $70.21M(+22.8%) | $20.29M(+2.2%) |
| Sep 2007 | - | $19.85M(+35.4%) |
| Jun 2007 | - | $14.66M(-4.9%) |
| Mar 2007 | - | $15.41M(+0.6%) |
| Dec 2006 | $57.19M(+22.3%) | $15.32M(+5.8%) |
| Sep 2006 | - | $14.48M(-1.8%) |
| Jun 2006 | - | $14.74M(+16.7%) |
| Mar 2006 | - | $12.64M(-3.8%) |
| Dec 2005 | $46.76M(+52.3%) | $13.14M(-20.3%) |
| Sep 2005 | - | $16.49M(+83.0%) |
| Jun 2005 | - | $9.01M(+10.9%) |
| Mar 2005 | - | $8.13M(-4.8%) |
| Dec 2004 | $30.70M(+45.4%) | $8.54M(+8.0%) |
| Sep 2004 | - | $7.90M(+14.5%) |
| Jun 2004 | - | $6.90M(-6.2%) |
| Mar 2004 | - | $7.36M(+70.1%) |
| Dec 2003 | $21.12M(+11.7%) | - |
| Jun 2003 | - | $4.32M(+4.7%) |
| Mar 2003 | - | $4.13M |
| Dec 2002 | $18.90M(-0.5%) | - |
| Dec 2001 | $18.99M(+21.9%) | - |
| Dec 2000 | $15.58M | - |
FAQ
- What is ACADIA Pharmaceuticals annual total expenses?
- What is the all time high annual total expenses for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals annual total expenses year-on-year change?
- What is ACADIA Pharmaceuticals quarterly total expenses?
- What is the all time high quarterly total expenses for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals quarterly total expenses year-on-year change?
What is ACADIA Pharmaceuticals annual total expenses?
The current annual total expenses of ACAD is $873.52M
What is the all time high annual total expenses for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high annual total expenses is $873.52M
What is ACADIA Pharmaceuticals annual total expenses year-on-year change?
Over the past year, ACAD annual total expenses has changed by +$73.70M (+9.21%)
What is ACADIA Pharmaceuticals quarterly total expenses?
The current quarterly total expenses of ACAD is $225.03M
What is the all time high quarterly total expenses for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high quarterly total expenses is $269.48M
What is ACADIA Pharmaceuticals quarterly total expenses year-on-year change?
Over the past year, ACAD quarterly total expenses has changed by +$34.41M (+18.05%)